journal article·2024-04-12

Cucurbituril-Based Porphyrin Cascade Assembly for Cell Imaging and Targeted Drug Delivery

Xing Yuan, De-Fang Xu, Yahui Song, Ying-Ming Zhang, Yu Liu

ACS Applied Polymer Materials· Volume 6· Issue 7
Publisher page

Abstract

Supramolecular assemblies based on multiple host–guest interactions have aroused widespread interest in the fabrication of innovative biomaterials. In this work, a combinational nanosupramolecule is constructed by an orthogonal two-step self-assembling process. The generation efficiency of reactive oxygen species and fluorescence emission intensity of pyridinium-appended porphyrin are greatly enhanced upon inclusion complexation with cucurbit[8]uril. Meanwhile, the introduction of β-cyclodextrin-grafted hyaluronic acid can facilitate the formation of secondary assemblies and endow them with the desired targeting ability toward cancer cells. After carrying doxorubicin hydrochloride as the loaded cargo, the resultant supramolecular nanoparticles exhibit much higher anticancer activity at the cellular level upon the near-infrared light irradiation. To be envisioned, such nanosupramolecular assemblies featuring both advantageous photodynamic and chemotherapeutic effects may be developed as more promising nanoplatforms for disease diagnosis and treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Supramolecular Chemistry and Complexes · Supramolecular Self-Assembly in Materials · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Chemistry, State Key Laboratory of Elemento-Organic Chemistry, Nankai University, Tianjin 300071, P. R. China

Department of Anesthesiology, Tianjin Fourth Central Hospital, Tianjin 300140, P. R. China

Funding

Natural Science Foundation of Tianjin Municipality · Nankai University · National Natural Science Foundation of China

References (38)

Show source-provided references
1. 10.1021/jacs.0c0544510.1021/jacs.0c05445 ↗
2. 10.1039/D0CS00011F10.1039/D0CS00011F ↗
3. 10.1021/jacs.0c0678310.1021/jacs.0c06783 ↗
4. 10.1021/jacs.3c1029510.1021/jacs.3c10295 ↗
5. 10.1021/acsabm.2c0031810.1021/acsabm.2c00318 ↗
6. 10.1002/anie.20191265410.1002/anie.201912654 ↗
7. 10.1021/acs.chemmater.0c0061510.1021/acs.chemmater.0c00615 ↗
8. 10.7150/thno.4006610.7150/thno.40066 ↗
9. 10.1016/j.cclet.2023.10864510.1016/j.cclet.2023.108645 ↗
10. 10.1002/tcr.20150026510.1002/tcr.201500265 ↗
11. 10.1021/acsami.1c0710610.1021/acsami.1c07106 ↗
12. 10.1021/acs.biomac.2c0027610.1021/acs.biomac.2c00276 ↗
13. 10.1002/adma.20180615810.1002/adma.201806158 ↗
14. 10.1021/acs.jmedchem.9b0106910.1021/acs.jmedchem.9b01069 ↗
15. 10.1016/j.matt.2020.09.01910.1016/j.matt.2020.09.019 ↗
16. 10.1039/c8cc07858k10.1039/c8cc07858k ↗
17. 10.1002/adfm.20120131610.1002/adfm.201201316 ↗
18. 10.1002/anie.20200979710.1002/anie.202009797 ↗
19. 10.1002/anie.20220676310.1002/anie.202206763 ↗
20. 10.1002/ijch.20170009210.1002/ijch.201700092 ↗
21. 10.1016/j.giant.2021.10006610.1016/j.giant.2021.100066 ↗
22. 10.1016/j.cclet.2021.08.00110.1016/j.cclet.2021.08.001 ↗
23. 10.1038/s41570-023-00555-110.1038/s41570-023-00555-1 ↗
24. 10.1002/adma.20220353410.1002/adma.202203534 ↗
25. 10.1002/anie.20220079910.1002/anie.202200799 ↗
26. 10.1002/chem.20230040810.1002/chem.202300408 ↗
27. 10.1021/jm401416810.1021/jm4014168 ↗
28. 10.1002/adom.20190215410.1002/adom.201902154 ↗
29. 10.1016/j.matt.2022.07.02210.1016/j.matt.2022.07.022 ↗
30. 10.1002/chem.20140261210.1002/chem.201402612 ↗
31. 10.1021/acs.accounts.2c0046210.1021/acs.accounts.2c00462 ↗
32. 10.1021/acs.jmedchem.2c0010510.1021/acs.jmedchem.2c00105 ↗
33. 10.1021/acs.jmedchem.2c0139810.1021/acs.jmedchem.2c01398 ↗
34. 10.1039/D3CC00735A10.1039/D3CC00735A ↗
35. 10.3390/pharmaceutics1502037410.3390/pharmaceutics15020374 ↗
36. 10.1016/S1773-2247(12)50032-810.1016/S1773-2247(12)50032-8 ↗
37. 10.1021/acsnano.9b1003710.1021/acsnano.9b10037 ↗
38. 10.1021/jacs.3c0920210.1021/jacs.3c09202 ↗